CIK 0001818382 · Non-accelerated filer<br>Smaller reporting company
Humacyte, Inc.
Sign in to watch- Ticker
- HUMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851763759
- Phone
- 919-313-9633
- Business address
- 2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC, 27713
- Former names
- Alpha Healthcare Acquisition Corp.
- Open-market buys, last 90 days
- $30,370
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$30,370. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-11 | Prichard Heather Ledbetter Chief Operating Officer | Grant or award · Stock Options (right to buy) | +525 | 2,100 | ||
| 2023-12-11 | Sander Dale A. CFO and Chief Corp. Deve. Off. | Grant or award · Stock Options (right to buy) | +525 | 2,100 | ||
| 2023-12-11 | Dougan Brady W Director | Grant or award · Stock Options (right to buy) | +525 | 2,100 | ||
| 2023-12-11 | Niklason Laura E President, CEO and Director | Grant or award · Stock Options (right to buy) | +525 | 2,100 | ||
| 2023-12-08 | Scheessele William John Chief Commercial Officer | Grant or award · Stock Options (right to buy) | +276,000 | 276,000 | ||
| 2023-12-08 | Prichard Heather Ledbetter Chief Operating Officer | Grant or award · Stock Options (right to buy) | +290,000 | 290,000 | ||
| 2023-12-08 | Parikh Shamik J Chief Medical Officer | Grant or award · Stock Options (right to buy) | +283,000 | 283,000 | ||
| 2023-12-08 | Cao Yang Chief Regulatory Officer | Grant or award · Stock Options (right to buy) | +210,000 | 210,000 | ||
| 2023-12-08 | Sander Dale A. CFO and Chief Corp. Deve. Off. | Grant or award · Stock Options (right to buy) | +301,000 | 301,000 | ||
| 2023-12-08 | Dougan Brady W Director | Grant or award · Stock Options (right to buy) | +803,000 | 803,000 | ||
| 2023-12-08 | Niklason Laura E President, CEO and Director | Grant or award · Stock Options (right to buy) | +803,000 | 803,000 | ||
| 2023-11-21 | Wallace Max N. Director | Option exercise | +6,564 | $1.19 | $8K | 56,550 |
| 2023-11-21 | Wallace Max N. Director | Option exercise · Stock Options (right to buy) | −6,564 | 0 | ||
| 2023-10-10 | Dougan Brady W Director | Option exercise | +114,420 | $1.19 | $136K | 1,384,660 |
| 2023-10-10 | Dougan Brady W Director | Option exercise · Stock Options (right to buy) | −114,420 | 48,176 | ||
| 2023-10-10 | Niklason Laura E President, CEO and Director | Option exercise | +114,420 | $1.19 | $136K | 1,384,660 |
| 2023-10-10 | Niklason Laura E President, CEO and Director | Option exercise · Stock Options (right to buy) | −114,420 | 48,176 | ||
| 2023-09-14 | Niklason Laura E President, CEO and Director | Sale | −2,000,000 | $2.78 | $5.6M | 6,191,140 |
| 2023-09-14 | Dougan Brady W Director | Sale | −2,000,000 | $2.78 | $5.6M | 6,191,140 |
| 2023-08-21 | Niklason Laura E President, CEO and Director | Sale | −602,443 | $3.39 | $2.0M | 8,191,140 |
Page 8 of 17 · 330 trades